CatherineKossMD
Infectious Disease • San Francisco, CAClinical Fellow, Internal Medicine, UCSF School of Medicine
Are you Dr. Koss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 35 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ucsf Department Of Medicine
505 Parnassus Avenue
San Francisco, CA 94143Phone+1 415-476-1528
Summary
- Dr. Catherine Koss, MD is an infectious disease specialist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center.
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2012 - 2014- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
Northwestern University The Feinberg School of MedicineClass of 2009
Certifications & Licensure
CA State Medical License 2011 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsDynamic choice HIV prevention with cabotegravir long-acting injectable in rural Uganda and Kenya: a randomised trial extension.Moses R Kamya, Laura B Balzer, James Ayieko, Jane Kabami, Elijah Kakande
The Lancet. HIV. 2024-11-01 - 1 citationsFirst Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.Catherine A Koss, Monica Gandhi, Elias K Halvas, Hideaki Okochi, Carolyn Chu
Open Forum Infectious Diseases. 2024-09-01 - 6 citationsRandomized Trial of Dynamic Choice HIV Prevention at Antenatal and Postnatal Care Clinics in Rural Uganda and Kenya.Jane Kabami, Catherine A Koss, Helen Sunday, Edith Biira, Marilyn Nyabuti
Journal of Acquired Immune Deficiency Syndromes. 2024-04-15
Press Mentions
- Social Networks Key to PrEP Uptake in Rural Kenya and UgandaMarch 11th, 2021
Universal Access to Preventive Drugs Could Reduce HIV Incidence in Sub-Saharan AfricaFebruary 9th, 2021- FDA Should Help Defeat Another Viral Epidemic—HIV—by Reclassifying PrEP and PEP over the CounterJuly 9th, 2020
- Join now to see all
